FDA Urges Strong Quality Pacts For Drugmakers, Contractors
Wading into an area that has been the subject of recent enforcement, the U.S. Food and Drug Administration on Friday explained its quality-control expectations for pharmaceutical companies and their contractors, hammering...To view the full article, register now.
Already a subscriber? Click here to view full article